Genetic alterations in primary melanoma in Taiwan

Medicine and Dentistry

• Nodular Melanoma 100%
• Cell Cycle 41%
• Aberration 41%
• Gene 35%
• Protein Tyrosine Kinase 23%
• Survival 17%
• Patient 11%
• Association 11%
• Comprehension 11%
• Venous Ulcer 11%
• Observation 5%
• Therapeutic Procedure 5%
• Development 5%
• Malignant Neoplasm 5%
• Drug 5%
• Chemotherapeutic Agent 5%
• Multivariate Analysis 5%
• Prognostic Factor 5%
• Prevalence 5%
• Neoplasm 5%
• Lymph Node Metastasis 5%
• Next Generation Sequencing 5%
• Mutation Rate 5%
• Copy Number Variation 5%
• Cutaneous Melanoma 5%
• Lymph Node Cell 5%